Changli Wang

19PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markersMolecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jan 08, 2025
Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer.

Mark M Awad, Patrick M Forde, Nicolas Girard

|Feb 15, 2023
Autoantibodies Drive Heart Damage Caused by Concomitant Radiation and PD-1 Blockade.

Bo Yan, D Craig Hooper, Zhiyong Yuan

|Nov 25, 2022
An open label, safety study of Asian patients with advanced non-small-cell lung cancer receiving second-line nivolumab monotherapy (CheckMate 870).

Shun Lu, Ying Cheng, Jianying Zhou

|Oct 13, 2022
Clinical analysis of 78 pulmonary sarcomatoid carcinomas with surgical treatment.

Ting Gong, Bin Jia, Chen Chen

|Aug 26, 2022
Updated Overall Survival and Exploratory Analysis From Randomized, Phase II EVAN Study of Erlotinib Versus Vinorelbine Plus Cisplatin Adjuvant Therapy in Stage IIIA Epidermal Growth Factor Receptor+ Non-Small-Cell Lung Cancer.

Dongsheng Yue, Shidong Xu, Qun Wang

|Jul 22, 2022
Pazopanib restricts small cell lung cancer proliferation via reactive oxygen species-mediated endoplasmic reticulum stress.

Yue Li, Chen Chen, Hai-Lin Liu

Pageof 4

Frequent Collaborators

4 joint publications

Zhenfa Zhang

3 joint publications

Chen-Guang Li

2 joint publications

Yue Li

2 joint publications

Shun Lu